The Breast Avastin Trial: phase II study of bevacizumab maintenance therapy after induction chemotherapy with docetaxel and capecitabine for the first-line treatment of patients with locally recurrent or metastatic breast cancer.

Bisagni, G; Musolino, A; Panebianco, M; De Matteis, A; Nuzzo, F; Ardizzoni, A; Gori, S; Gamucci, T; Passalacqua, R; Gnoni, R; Moretti, G; Boni, C

Bisagni, G; Musolino, A; Panebianco, M; De Matteis, A; Nuzzo, F; Ardizzoni, A; Gori, S; Gamucci, T; Passalacqua, R; Gnoni, R; Moretti, G; Boni, C.

Affiliation

Bisagni G; Oncology Unit, Department of Oncology, Azienda Ospedaliera ASMN, Istituto di Ricovero e Cura a Carattere Scientifico, Reggio Emilia, Italy. bisagni.giancarlo@asmn.re.it

Cancer Chemother Pharmacol ; 71(4): 1051-7, 2013 Apr.

Article in En | MEDLINE | ID: mdl-23377310

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Breast Neoplasms/drug therapy; Neoplasm Recurrence, Local/drug therapy; Adult; Aged; Antibodies, Monoclonal, Humanized/administration & dosage; Antineoplastic Combined Chemotherapy Protocols/adverse effects; Bevacizumab; Breast Neoplasms/mortality; Breast Neoplasms/pathology; Capecitabine; Deoxycytidine/administration & dosage; Deoxycytidine/analogs & derivatives; Docetaxel; Female; Fluorouracil/administration & dosage; Fluorouracil/analogs & derivatives; Humans; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local/pathology; Patient Compliance; Taxoids/administration & dosage

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Breast Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Neoplasm Recurrence, Local Type of study: Clinical_trials Limits: Adult / Aged / Female / Humans / Middle aged Language: En Year: 2013 Type: Article

Fulltext

XML

PubMed Links

Search on Google